gymnema
Gymnema sylvestre
Gymnema sylvestre 是一种传统植物，在阿育吠陀医学中主要用于管理糖尿病。它也被用于中医（TCM）以类似的目的。科学研究表明，Gymnema sylvestre 可能会影响味觉感知，减少对糖的甜度感知，并可能降低糖摄入量。在动物模型中，它显示出一些减轻炎症标志物和改善肺功能的希望。然而，其对血糖水平的影响目前没有强有力的证据支持。尚未报告重大安全问题或已知药物相互作用，使其在传统应用时通常被认为是安全的。
- 传统用于
- 糖尿病
- 传统体系
- 阿育吠陀
- 最佳证据
- D
- 注意事项
- —
仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。
传统用途
- 糖尿病
科学怎么说
- Gymnema sylvestre 并未显著改变在可可模型中瑞鲍迪苷A的苦味感知，这表明蔗糖具有独立于甜度的瑞鲍迪苷A苦味抑制作用。
- 使用从Gymnema衍生的化合物抑制外周甜味信号传导，减少了大鼠对蔗糖的选择和摄入，并降低了人类感知的甜度、愉悦感和欲望。
- Gymnemagenin-3-O-葡萄糖醛酸酯治疗减少了LPS诱导的急性肺损伤模型中的炎症标志物并改善了肺功能。
- 研究确定了139种增强PPARγ活性的传统中药样本，包括显示出抑制作用的绞股蓝。
Frequently asked questions
What is gymnema?
gymnema (Gymnema sylvestre) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What is gymnema traditionally used for?
Traditional sources record gymnema for: 糖尿病. This reflects traditional use, not a proven medical treatment.
Which traditions use gymnema?
gymnema appears in these traditions in our sources: Ayurveda.
What does the scientific evidence say about gymnema?
4 sourced findings are recorded for gymnema; the strongest carries evidence grade D. For example: Gymnema sylvestre 并未显著改变在可可模型中瑞鲍迪苷A的苦味感知，这表明蔗糖具有独立于甜度的瑞鲍迪苷A苦味抑制作用。
How strong is the evidence for gymnema?
The strongest finding for gymnema carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is gymnema safe? What are the side effects?
No major safety issues are recorded for gymnema in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does gymnema interact with medications?
No drug interactions are recorded for gymnema in our sources. This does not rule them out — check with a pharmacist.
Is gymnema a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
来源
- T2 Gymnemagenin-3-O-glucuronide mitigates lipopolysaccharide-induced acute lung inflammation/injury by regulating the NF-κB/MAPK signalling. literature abstract metadata
- T2 Large-Scale Evaluation of Traditional Chinese Medicines Reveals Potential PPARγ Modulators for Type 2 Diabetes Management. literature abstract metadata
- T2 Targeting sweet taste as a strategy to reduce sugar reward: Preliminary evidence from preclinical and human studies. literature abstract metadata
- T2 Sweetness-independent bitterness suppression of rebaudioside A by sucrose in a cocoa model. literature abstract metadata
- T3 Gymnema sylvestre CC BY-SA 4.0